TAVANTA THERAPEUTICS Trademark

Trademark Overview


On Thursday, May 14, 2020, a trademark application was filed for TAVANTA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TAVANTA THERAPEUTICS trademark a serial number of 88916837. The federal status of this trademark filing is REGISTERED as of Tuesday, October 12, 2021. This trademark is owned by Druggability Technologies Holdings, Ltd. The TAVANTA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, medical and pharmaceutical research and development, namely, development of new pharmaceutical formulations, development of pharmaceutical formulations for efficient drug release, development of clinical uses and treatments for new chemical entities and known pharmaceutical compounds; research and development of new pharmaceutical formulations; research and development of pharmaceutical formulations for efficient drug release; research and development of pharmaceuticals, namely, pharmaceuticals for treating cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; research and development of new chemical entities and known pharmaceutical compounds; research and development of medicines, namely, for the treatment of cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; scientific investigations for medical purposes; research and development of medicines, namely, new chemical entities and kn...
tavanta therapeutics

General Information


Serial Number88916837
Word MarkTAVANTA THERAPEUTICS
Filing DateThursday, May 14, 2020
Status700 - REGISTERED
Status DateTuesday, October 12, 2021
Registration Number6521716
Registration DateTuesday, October 12, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 13, 2020

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesScientific, medical and pharmaceutical research and development, namely, development of new pharmaceutical formulations, development of pharmaceutical formulations for efficient drug release, development of clinical uses and treatments for new chemical entities and known pharmaceutical compounds; research and development of new pharmaceutical formulations; research and development of pharmaceutical formulations for efficient drug release; research and development of pharmaceuticals, namely, pharmaceuticals for treating cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; research and development of new chemical entities and known pharmaceutical compounds; research and development of medicines, namely, for the treatment of cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; scientific investigations for medical purposes; research and development of medicines, namely, new chemical entities and known pharmaceutical compounds

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 28, 2020
Primary Code042
First Use Anywhere DateTuesday, September 1, 2020
First Use In Commerce DateTuesday, September 1, 2020

Trademark Owner History


Party NameTAVANTA THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRADNOR, PA 19087

Party NameDruggability Technologies Holdings, Ltd
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDublin 2
IE

Party NameDruggability Technologies Holdings, Ltd
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDublin 2
IE

Party NameDruggability Technologies Holdings, Ltd
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDublin 2
IE

Trademark Events


Event DateEvent Description
Wednesday, July 27, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 12, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, September 9, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 8, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 3, 2021ASSIGNED TO LIE
Friday, July 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 21, 2021NON-FINAL ACTION E-MAILED
Wednesday, July 21, 2021SU - NON-FINAL ACTION - WRITTEN
Tuesday, June 22, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 8, 2021USE AMENDMENT FILED
Thursday, June 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 8, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, December 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 13, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 18, 2020NON-FINAL ACTION E-MAILED
Tuesday, August 18, 2020NON-FINAL ACTION WRITTEN
Wednesday, August 12, 2020ASSIGNED TO EXAMINER
Thursday, May 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 18, 2020NEW APPLICATION ENTERED IN TRAM